The Spanish Competition Authority opens formal proceedings in the pharmaceutical industry (Pfizer)

On 19 December 2012, the Spanish Competition Authority (“CNC”) announced that it had opened formal proceedings against Pfizer over concerns that the company may have engaged in anti-competitive practices in the market for medicines based on

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Peter L'Ecluse, The Spanish Competition Authority opens formal proceedings in the pharmaceutical industry (Pfizer), 19 December 2012, e-Competitions Bulletin Pharma & Dominance, Art. N° 58215

Visites 221

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues